Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Meradimate
2. 134-09-8
3. Meradimate [inn]
4. Menthyl-o-aminobenzoate
5. (5-methyl-2-propan-2-ylcyclohexyl) 2-aminobenzoate
6. Anthranilic Acid, P-menth-3-yl Ester
7. Cyclohexanol, 5-methyl-2-(1-methylethyl)-, 2-aminobenzoate
8. 2-isopropyl-5-methylcyclohexyl 2-aminobenzoate
9. J9qgd60ouz
10. 5-methyl-2-(propan-2-yl)cyclohexyl 2-aminobenzoate
11. Cyclohexanol,5-methyl-2-(1-methylethyl)-, 1-(2-aminobenzoate)
12. Ncgc00159361-02
13. Dsstox_cid_27871
14. Dsstox_rid_82624
15. Dsstox_gsid_47895
16. Cas-134-09-8
17. Ccris 2468
18. Menthyl O-aminobenzoate
19. Einecs 205-129-8
20. Unii-j9qgd60ouz
21. Meradimate [usan:usp:inn]
22. Neo Heliopan Ma
23. Meradimate (usp/inn)
24. Meradimate [usan]
25. Menthyl Anthranilate, 98%
26. Meradimate [mart.]
27. Meradimate [usp-rs]
28. Meradimate [who-dd]
29. Schembl18884
30. 5-methyl-2-(1-methylethyl)cyclohexanol-2-aminobenzoate
31. Chembl1597075
32. Dtxsid3047895
33. Menthyl Anthranilate [mi]
34. Chebi:135974
35. Meradimate [usp Monograph]
36. Menthyl Anthranilate [inci]
37. Tox21_111602
38. Tox21_200561
39. Bbl028008
40. Stk083062
41. Akos001387784
42. Akos017278349
43. Db11096
44. Menthyl Anthranilate, Analytical Standard
45. Ncgc00159361-06
46. Ncgc00258115-01
47. Vs-08642
48. 2-aminobenzoic Acid P-menthane-3-yl Ester
49. Db-042217
50. Ft-0631778
51. D04927
52. Z262222228
53. 2-amino-benzoic Acid 2-isopropyl-5-methyl-cyclohexyl Ester
54. 2-aminobenzoic Acid (2-isopropyl-5-methyl-cyclohexyl) Ester
55. Meradimate, United States Pharmacopeia (usp) Reference Standard
56. Cyclohexanol, 5-methyl-2-(1-methylethyl)-, 1-(2-aminobenzoate)
57. Menthyl Anthranilate, Pharmaceutical Secondary Standard; Certified Reference Material
Molecular Weight | 275.4 g/mol |
---|---|
Molecular Formula | C17H25NO2 |
XLogP3 | 5.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 4 |
Exact Mass | 275.188529040 g/mol |
Monoisotopic Mass | 275.188529040 g/mol |
Topological Polar Surface Area | 52.3 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 329 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 3 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Meradimate is used as an active ingredient in sunscreens or as a sunblock factor in different products. It fits under the category of broad-spectrum absorbent agent. These characteristics are important to consider due to the fact that this kind of ingredients can either absorb or reflect UV radiation. It is also important to know the type of rays that cover. UVA rays are the responsible of causing sun damage and reaching deeper layers of the skin while UVB can only cause sunburn in the outer layer of the skin. When an agent is of broad spectrum, this means that this agent is capable of acting in both UVA and UVB rays.
Meradimate effect provides a low-level, broad-spectrum protecting coverage effect.
Absorption
Meradimate is not absorbed through the skin.
Route of Elimination
As meradimate is not absorbed, this pharmacokinetic property is not relevant.
Volume of Distribution
As meradimate is not absorbed, this pharmacokinetic property is not relevant.
Clearance
As meradimate is not absorbed, this pharmacokinetic property is not relevant.
As meradimate is not absorbed, this pharmacokinetic property is not relevant.
As meradimate is not absorbed, this pharmacokinetic property is not relevant.
Meradimate acts by absorbing both the UVA and UVB radiation, this provides this ingredient with a broad spectrum and it explains why it is highly used in different products such as lip balms, lipsticks, and moisturizers. Its protective effective action does not cover completely the UVA rays as it only reaches 336 nm. This has been proven even thought meradimate has a theoretical protective coverage range between 200-380 nm. Its function is related to the intrinsic structure of meradimate which is an ortho-disubstituted aminobenzoate. This structure allows easy electron delocalization and shifts in the maximum absorption.
Regulatory Info : OTC
Registration Country : Canada
Brand Name : BLISTEX ULTRA LIP BALM
Dosage Form : OINTMENT
Dosage Strength : 4.8%
Packaging : 4GM
Approval Date :
Application Number : 2051524
Regulatory Info : OTC
Registration Country : Canada
Regulatory Info : OTC
Registration Country : Canada
Brand Name : CERAVE
Dosage Form : LOTION
Dosage Strength : 5%/W/W
Packaging : 89ML
Approval Date :
Application Number : 2410923
Regulatory Info : OTC
Registration Country : Canada
Regulatory Info : OTC
Registration Country : Canada
Brand Name : MARCELLE/ OIL FREE MULTI-DÉFENSE LOTION SPF 15 FPS/ FLUIDE MULTI-DÉFENSE SANS HUILE
Dosage Form : LOTION
Dosage Strength : 4%
Packaging : 120ML
Approval Date :
Application Number : 2093006
Regulatory Info : OTC
Registration Country : Canada
Regulatory Info : OTC
Registration Country : Canada
Brand Name : MARCELLE/MULTI-DEFENSE CREAM/CRÈME MULTI-DÉFENSE/SPF 15 FPS
Dosage Form : CREAM
Dosage Strength : 4%
Packaging : 50ML
Approval Date :
Application Number : 2093014
Regulatory Info : OTC
Registration Country : Canada
Related Excipient Companies
Excipients by Applications
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?